Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype
DrugBaron
JANUARY 31, 2024
Both the cost and the time required for each new drug approval have increased exponentially for decades (aptly tagged ‘Eroom’s Law’, being the inverse of price drops and speed gains in the semiconductor industry). There is, of course, no evidence of whether the claims made for AI in discovery and development are hype or reality.
165 
Let's personalize your content